FTC’s sham petition loss to Shire tees up potential federal court troubles

Washington, D.C. (April 2, 2018) -- Drugmaker Shire has defeated a Federal Trade Commission lawsuit claiming that it delayed generic versions of the gastrointestinal drug Vancocin, despite a federal judge ruling that the company’s past conduct could be viewed as anticompetitive....

Related Sections